Hypothesis / aims of study
Bulbar artificial urinary sphincter (AUS) is the gold standard for treatment of stress urinary incontinence (SUI) in men following treatment for prostate cancer (PCa). As our population ages, we must ensure efficacious solutions for older men with SUI post-PCa treatment is available. Occasionally, age could influence the decision of either offering by surgeons or accepting by patient to have such treatment. This would impact the quality of life in older population following prostate cancer treatment.
We believe age should not be a factor in offering an AUS to patients with SUI post-PCa treatment. This study assessed whether age influenced the outcome of AUS for SUI post-PCa treatment.
Study design, materials and methods
A retrospective notes review of all patients having AUS for SUI following PCa treatment between 2006 and 2019. A 7-point Patient Global Impression of Improvement assessment (PGII) comparing pre-operative and post-operative condition (where 1: very much better, 4: the same and 7: very much worse) was completed for all patients a minimum of 6 months following insertion of their AUS. The AUS was deemed to have been successful if PGII was 1 or 2.
Older men were defined as those ≥ 75 years of age. Statistical analysis was done via Students T test, Chi Square and Mann Whitney with significance determined as P < 0.5
Interpretation of results
Bulbar AUS has an overall success rate of 73.4%, which was described as ‘very much improved’ or ‘much improved’ condition with a minimum of 6 months after insertion.
There was no significant difference noted in the success rate between older and younger men